E-selectin targeting to visualize tumors in vivo
E-selectin targeting to visualize tumors in vivo
复制标题
DOI:
10.1002/cmmi.367
复制
发表时间:
2010-03-01
影响因子:
--
通讯作者:
Seno, Masaharu
中科院分区:
文献类型:
--
作者:
Hirai, Masahiko;Hiramatsu, Yoshie;Seno, Masaharu
Generally angiogenic factors induce the expression of E-selectin in vascular endothelial cells in the tumors. In this study, we employed an anti-E-selectin monoclonal antibody to target tumors in vivo and evaluated an optical imaging reagent to visualize tumor regions. The anti-E-selectin antibody was conjugated on the surface of liposomes, which encapsulated the near-infrared fluorescent substances Cy3 or Cy5.5. The liposomes efficiently recognized human umbilical vein endothelial cells only when E-selectin was induced by angiogenic factors such as TNF-alpha in vitro. Cy5.5 encapsulated into liposomes that were conjugated with an anti-E-selectin antibody successfully visualized Ehrlich ascites tumor cells when transplanted into mice. Thus, E-selectin targeting with liposomes containing a near-infrared fluorescent dye was found effective in visualizing tumors in vivo. This strategy should be extremely useful as a method to identify sentinel lymphatic nodes and angiogenic tumors as well as use for drug delivery to tumor cells. Copyright (C) 2010 John Wiley & Sons, Ltd.